Tag:
AMRI
Latest Headlines
Latest Headlines
AMRI sees Q1 drops, but maintains positive financial outlook for 2012
As Albany Molecular Research ($AMRI) progresses into 2012, it is driven to recoup revenue it lost out on in the first quarter.
AMRI gets 'smart' with its contract services
By launching what it calls SmartSourcing, the Albany CRMO hopes to provide clients with insourcing and outsourcing opportunities that lead to high-quality performance and scientific expertise without breaking the bank.
AMRI gets research and manufacturing deal for Biota's flu antiviral
AMRI will further develop and manufacture laninamivir, an influenza antiviral, as it pursues an NDA with the FDA.
AMRI names quality control director for troubled plant, following lead of J&J, Novartis, others
AMRI ($AMRI) has named Tom McGrath as director of quality for aseptic services at its Burlington, MA, facility.
Teva and Barr settle patent dispute
Albany Molecular Research (AMRI) announced this morning an agreement with Teva Pharmaceuticals and Barr Laboratories to settle patent infringement litigation. The settlement involved the U.S. dispute
